SYNTHESIS OF TRIGGERABLE FUSOGENS FOR MEMBRANE BILAYERS
双层膜可触发融合剂的合成
基本信息
- 批准号:2629050
- 负责人:
- 金额:$ 16.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-01 至 2002-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): The primary objective of
the proposed research is to synthesize new compounds that can be used to
control lipid-mediated membrane fusion. An interdisciplinary project is
proposed involving synthetic chemistry, theory, biophysics, and cell biology
aimed at expanding the range of materials that are currently available for
accelerating this fundamentally important process. The proposed materials
will be incorporated within guest membrane vesicles as masked, nonfusogenic
compounds that will become fusogenic upon localized chemical triggering by
exposure to low pH or oxidative environment--an unmasking process that is
analogous to influenza hemagglutinin and other viral protein-based membrane
fusion pathways. Preliminary computational experiments have been used to
design a set of synthetic target molecules, containing vinyl ether bonding
motifs at optimal strategic loci, that will efficiently promote membrane
fusion after degradation of this linkage has been triggered. Synthetic
methodology developed by Run & Thompson [J. Org. Chem. 1994 59 5758; Chem.
Eur.J. 1996 2 1505] will be used to install the labile vinyl ether linkages
in the proposed series of masked amphiphilic fusogens. The resulting
compounds will then be tested for their ability to promote membrane fusion
in model membrane systems under experimental conditions capable of deploying
the fusogen via vinyl ether bond cleavage. HPLC analysis and membrane
fusion fluorescence assays will be used to monitor the rates of fusogen
unmasking, vesicle lipid mixing, and vesicle contents mixing after chemical
activation has occurred; these results will be compared with the predictions
made by mean-field single chain theory. Physical characterization of the
membrane structures, before and after triggering, will also be performed
using 31P NMR, freeze-fracture electron microscopy, and x-ray scattering
techniques. The most efficient fusogens in the model membrane experiments
will be assayed for their efficacy in promoting cytoplasmic release from KB
cell endosomal compartments targeted via folate-conjugated DSPE-PEG.
Cytoplasmic membrane fusion efficiency, in the absence of endosomal uptake,
will also be determined using flow cytometry and laser confocal microscopy
techniques to evaluate the utility of these materials for intracellular
delivery hydrophilic reagents that typically experience slow rates of
membrane translocation (e.g., peptides, antisense oligonucleotides, and
plasmids).
描述(改编自申请人摘要):主要目的
拟议的研究是合成新的化合物,
控制脂质介导的膜融合。 一个跨学科的项目是
涉及合成化学、理论、生物物理学和细胞生物学
旨在扩大目前可用的材料范围,
加速这一至关重要的进程。 申报材料
将被掺入客体膜囊泡中,作为掩蔽的、非融合的
在局部化学触发后将变得融合的化合物,
暴露于低pH值或氧化环境-一个暴露过程,
类似于流感血凝素和其它病毒蛋白质基膜
融合途径 初步的计算实验已经被用来
设计一套合成目标分子,含有乙烯基醚键
在最佳战略位点的基序,这将有效地促进膜
在该连接的降解已经被触发之后的融合。 合成
由Run & Thompson开发的方法[J. Org. Chem.
Eur.J. 1996 2 1505]将用于安装不稳定的乙烯基醚键
在所提出的一系列掩蔽的两亲性融合子中。 所得
然后将测试化合物促进膜融合的能力
在能够展开的实验条件下的模型膜系统中
通过乙烯基醚键断裂而形成融合剂。 HPLC分析和膜
融合荧光测定将用于监测融合剂的速率
暴露、囊泡脂质混合和化学后囊泡内容物混合
激活已经发生;这些结果将与预测进行比较
平均场单链理论。 的物理特性
膜结构,在触发之前和之后,也将执行
使用31 P NMR、冷冻断裂电子显微镜和X射线散射
技术. 模型膜实验中最有效的融合剂
将测定它们促进KB细胞质释放的功效
通过叶酸缀合的DSPE-PEG靶向细胞内体区室。
在不存在内体摄取的情况下,细胞质膜融合效率,
也将使用流式细胞术和激光共聚焦显微镜来确定
技术,以评估这些材料的细胞内的效用,
递送亲水性试剂通常经历缓慢的
膜易位(例如,肽,反义寡核苷酸,和
质粒)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID H THOMPSON其他文献
DAVID H THOMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID H THOMPSON', 18)}}的其他基金
Development of Long-circulating, Degradable Gd-Polyrotaxane MR Agents
长循环、可降解Gd-聚轮烷MR剂的研制
- 批准号:
8824207 - 财政年份:2014
- 资助金额:
$ 16.72万 - 项目类别:
Development of Long-circulating, Degradable Gd-Polyrotaxane MR Agents
长循环、可降解Gd-聚轮烷MR剂的研制
- 批准号:
8935773 - 财政年份:2014
- 资助金额:
$ 16.72万 - 项目类别:
Development of Bioresponsive Lipids for Intracellular Delivery
用于细胞内递送的生物响应性脂质的开发
- 批准号:
8018991 - 财政年份:2009
- 资助金额:
$ 16.72万 - 项目类别:
Development of Bioresponsive Lipids for Intracellular Delivery
用于细胞内递送的生物响应性脂质的开发
- 批准号:
8214528 - 财政年份:2009
- 资助金额:
$ 16.72万 - 项目类别:
Development of Bioresponsive Lipids for Intracellular Delivery
用于细胞内递送的生物响应性脂质的开发
- 批准号:
7782696 - 财政年份:2009
- 资助金额:
$ 16.72万 - 项目类别:
Development of Bioresponsive Lipids for Intracellular Delivery
用于细胞内递送的生物响应性脂质的开发
- 批准号:
8019667 - 财政年份:2009
- 资助金额:
$ 16.72万 - 项目类别:
Development of an ICMT Supported Membrane Sensor
ICMT 支持的薄膜传感器的开发
- 批准号:
7037706 - 财政年份:2006
- 资助金额:
$ 16.72万 - 项目类别:
Crystallization of His-tag Proteins on Nanostructured 1D & 2D Template Interface
His 标签蛋白在纳米结构一维上的结晶
- 批准号:
7244087 - 财政年份:2006
- 资助金额:
$ 16.72万 - 项目类别:
Development of an ICMT Supported Membrane Sensor
ICMT 支持的薄膜传感器的开发
- 批准号:
7190479 - 财政年份:2006
- 资助金额:
$ 16.72万 - 项目类别:
Development of an ICMT Supported Membrane Sensor
ICMT 支持的薄膜传感器的开发
- 批准号:
7560063 - 财政年份:2006
- 资助金额:
$ 16.72万 - 项目类别:
相似海外基金
MRI: Acquisition of an X-ray Diffractometer for Research and Training in Chemical Structure-Function Studies
MRI:购买 X 射线衍射仪用于化学结构-功能研究的研究和培训
- 批准号:
1726630 - 财政年份:2017
- 资助金额:
$ 16.72万 - 项目类别:
Standard Grant














{{item.name}}会员




